Free tool
FAERS Monitor: Cialis
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021368 or its brand name (Cialis, Tadalafil). Reports on generic versions are filed under their own applications.
Reports
55,369
Serious
31,408
57% of reports
Hospitalization
15,937
Death reported
3,985
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- headache5,379
- drug ineffective5,165
- dyspnoea4,744
- diarrhoea3,734
- fatigue3,414
- nausea3,135
- dizziness2,652
- cough2,294
- asthenia2,034
- off label use1,991
- back pain1,779
- pain1,775
- death1,749
- pain in extremity1,625
- vomiting1,591
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1,183 |
| 2005 | 1,297 |
| 2006 | 974 |
| 2007 | 324 |
| 2008 | 370 |
| 2009 | 493 |
| 2010 | 599 |
| 2011 | 733 |
| 2012 | 732 |
| 2013 | 740 |
| 2014 | 1,105 |
| 2015 | 6,447 |
| 2016 | 2,071 |
| 2017 | 1,785 |
| 2018 | 2,440 |
| 2019 | 4,154 |
| 2020 | 3,448 |
| 2021 | 3,349 |
| 2022 | 4,020 |
| 2023 | 4,681 |
| 2024 | 4,980 |
| 2025 | 5,648 |
| 2026 | 3,796 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,998,790 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| headacheSignal | 5,379 | 3.3 | 3.2 | 8,702 |
| dyspnoeaSignal | 4,744 | 3.2 | 3.1 | 7,318 |
| coughSignal | 2,294 | 3.1 | 3.0 | 3,329 |
| back painSignal | 1,779 | 2.9 | 2.8 | 2,257 |
| diarrhoeaSignal | 3,734 | 2.2 | 2.1 | 2,519 |
| pain in extremitySignal | 1,625 | 2.1 | 2.0 | 945 |
| astheniaSignal | 2,034 | 2.1 | 2.0 | 1,123 |
| dizzinessSignal | 2,652 | 2.0 | 2.0 | 1,401 |
| fatigue | 3,414 | 1.7 | 1.6 | 945 |
| nausea | 3,135 | 1.5 | 1.5 | 552 |
| drug ineffective | 5,165 | 1.5 | 1.5 | 886 |
| vomiting | 1,591 | 1.3 | 1.2 | 103 |
| pain | 1,775 | 1.1 | 1.0 | 16 |
| off label use | 1,991 | 0.9 | 0.8 | 45 |
| death | 1,749 | 0.8 | 0.7 | 124 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.